Texas-based Galderma Laboratories has developed a once-daily, topical acne treatment that combines the retinoid adapalene with the anti-microbial treatment benzoyl peroxide. The product, called Epiduo, targets three out of the four causes of acne and will simplify acne management, according to the company. In clinical trials, patients who used the gel experienced low side effects, with some showing improvements after just one week. Approved by the Food and Drug Administration in December 2008 for use in patients 12 and older, Epiduo should be available soon by prescription.

Trackback URI | Comments RSS